THIAMIJECT INJECTION - LIQ IM IV 100MG/ML 100 MG
THIAMINE HYDROCHLORIDE : 100 MG · DIN 02193221 · OMEGA LABORATORIES LIMITED
Health Canada status: MARKETED
What is THIAMIJECT INJECTION - LIQ IM IV 100MG/ML?
THIAMIJECT INJECTION - LIQ IM IV 100MG/ML 100 MG contains THIAMINE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02193221, held by OMEGA LABORATORIES LIMITED, supplied as LIQUID for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 16-Jul-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is THIAMIJECT INJECTION - LIQ IM IV 100MG/ML called?
The same molecule, THIAMINE (VIT B1), is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Betavit | Latin | Australia |
| NEUROBION ampoules | Latin | Saudi Arabia |
| NEURO-B FILM COATED TABLETS | Latin | Saudi Arabia |
| NEUROCOMB I.M INJECTION | Latin | Saudi Arabia |
| NEURORUBINE SOLUTION | Latin | Saudi Arabia |
| NEURORUBINE-FORTE | Latin | Saudi Arabia |
| NEUROVIT AMPOULES | Latin | Saudi Arabia |
| NEUROVIT tablet | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02193221 |
|---|---|
| Brand name | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML |
| Generic / active ingredient | THIAMINE HYDROCHLORIDE : 100 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 100 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Ethical |
| ATC code | A11DA01 THIAMINE (VIT B1) |
| AHFS class | 88:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-Jul-1998 |
| Original market date | 1998-07-16 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02193221 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2193221 |
| Brand name | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML |
| Active ingredient / INN | THIAMINE HYDROCHLORIDE : 100 MG |
| ATC code | A11DA01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A11 |
| AHFS class | 88:08.00 |
| Health Canada schedule | Ethical |
| Biosimilar biologic | No |
| Market authorization holder | OMEGA LABORATORIES LIMITED |
Which pack is which?
| Strength on the label | 100 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A11DA01 THIAMINE (VIT B1). 2 of 35 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| VITAMIN B1 | 100 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00816078 |
| ACTI-THIAMINE CAPLET 100MG | 100 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | DIN 01900641 |
| B-1 CAPS 500MG | 500 MG | CAPSULE | TWIN LABORATORIES INC. | CANCELLED POST MARKET | DIN 01984128 |
| B1 400MG CTR TAB | 400 MG | TABLET (EXTENDED-RELEASE) | BIOENERGY INC. | CANCELLED POST MARKET | DIN 00543187 |
| B1 TAB 100MG | 100 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 00450669 |
| BETAXIN | 100 MG | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 02241983 |
| BETAXIN LIQ 100MG/ML | 100 MG | LIQUID | SANOFI CANADA, INC. | CANCELLED POST MARKET | DIN 02017547 |
| BEWON ELIXIR | .05 MG | LIQUID | LABORATOIRES CHARTON LABORATORIES | CANCELLED POST MARKET | DIN 02155303 |
| BEWON ELIXIR 0.05MG/ML | .05 MG | ELIXIR | WYETH-AYERST CANADA INC. | CANCELLED POST MARKET | DIN 02041561 |
| THIAMINE HCL INJ 100MG/ML | 100 MG | LIQUID | KRIPPS PHARMACY LTD. | DORMANT | DIN 00463493 |
Who else supplies THIAMINE (VIT B1) worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. THIAMINE (VIT B1) appears in 31 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does THIAMINE (VIT B1) cost around the world?
THIAMINE (VIT B1) is listed on 4 national price registers Nexara tracks, across 32 pack listings published on 4 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 1 | 14 | 03 Sep 2026 |
| Saudi Arabia | public | 10 | 11 | 01 Sep 2026 |
| Australia | ex-manufacturer | 1 | 4 | 08 Sep 2026 |
| United Kingdom | hospital | 3 | 3 | 31 Aug 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for THIAMIJECT INJECTION - LIQ IM IV 100MG/ML
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.